TGFB1 and stroke disorder: In 2008, Ma and colleagues demonstrated that intranasal administration of TGF‐β1 was able to reduce infarct volume, improved functional recovery, and enhanced neurogenesis in mice after stroke.[163] Recently, Zhang et al.